Another driver alteration usually found in young and non-smoker NSCLC patients is anaplastic lymphoma kinase (ALK)-translocation (118), for which several TKIs have been developed and have dramatically changed prognosis of patients carrying this molecular rearrangement (119, 120). The gene discussed is ALK; the disease is non-small cell lung carcinoma.